Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Tanner

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Journal of the American Academy of Dermatology|March 1, 1984
Common and uncommon cutaneous findings in patients with ataxia-telangiectasiaL E Cohen, D J Tanner, H G Schaefer, et al.
Journal of the American Academy of Dermatology|September 1, 1986
Treatment of basal cell carcinoma with intralesional interferonH T Greenway, R C Cornell, D J Tanner, et al.
Archives of Dermatology|August 1, 1990
The effect of an intralesional sustained-release formulation of interferon alfa-2b on basal cell carcinomasL Edwards, S B Tucker, D Perednia, et al.
Archives of Dermatology|March 1, 1986
Intralesional recombinant alpha-2 interferon for the treatment of patients with condyloma acuminatum or verruca plantarisJ C Vance, B J Bart, R C Hansen, et al.
Plant Disease|February 7, 2019
Identification, Virulence, and Distribution of Two Biovars of Pseudomonas syringae pv. actinidiae in New ZealandJ L Vanneste, J Yu, D A Cornish, et al.
Archives of Dermatology|November 11, 1992
Treatment of cutaneous squamous cell carcinomas by intralesional interferon alfa-2b therapyL Edwards, B Berman, R P Rapini, et al.
Journal of the American Academy of Dermatology|October 1, 1990
Intralesional interferon therapy for basal cell carcinomaR C Cornell, H T Greenway, S B Tucker, et al.
Clinical Therapeutics|May 20, 1998
Mometasone furoate 0.1%-salicylic acid 5% ointment versus mometasone furoate 0.1% ointment in the treatment of moderate-to-severe psoriasis: a multicenter studyJ Koo, C A Cuffie, D J Tanner, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of the American Academy of Dermatology|March 1, 1984
Common and uncommon cutaneous findings in patients with ataxia-telangiectasiaL E Cohen, D J Tanner, H G Schaefer, et al.
Journal of the American Academy of Dermatology|September 1, 1986
Treatment of basal cell carcinoma with intralesional interferonH T Greenway, R C Cornell, D J Tanner, et al.
Archives of Dermatology|August 1, 1990
The effect of an intralesional sustained-release formulation of interferon alfa-2b on basal cell carcinomasL Edwards, S B Tucker, D Perednia, et al.
Archives of Dermatology|March 1, 1986
Intralesional recombinant alpha-2 interferon for the treatment of patients with condyloma acuminatum or verruca plantarisJ C Vance, B J Bart, R C Hansen, et al.
Plant Disease|February 7, 2019
Identification, Virulence, and Distribution of Two Biovars of Pseudomonas syringae pv. actinidiae in New ZealandJ L Vanneste, J Yu, D A Cornish, et al.
Archives of Dermatology|November 11, 1992
Treatment of cutaneous squamous cell carcinomas by intralesional interferon alfa-2b therapyL Edwards, B Berman, R P Rapini, et al.
Journal of the American Academy of Dermatology|October 1, 1990
Intralesional interferon therapy for basal cell carcinomaR C Cornell, H T Greenway, S B Tucker, et al.
Clinical Therapeutics|May 20, 1998
Mometasone furoate 0.1%-salicylic acid 5% ointment versus mometasone furoate 0.1% ointment in the treatment of moderate-to-severe psoriasis: a multicenter studyJ Koo, C A Cuffie, D J Tanner, et al.
Pageof 3